We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JAH
501
DELISTED
JARDEN CORPORATION
JAH
| $9.08M | 0.03% |
226,545
-3,432
| -1% | -$134K |
|
502
Corpay
CPAY
$25B
| $9.07M | 0.03% |
63,819
-1,554
| -2% | -$214K |
|
503
Packaging Corp of America
PKG
$21.9B
| $9.04M | 0.03% |
141,591
+537
| +0.4% | +$36.1K |
|
504
BioMarin Pharmaceuticals
BMRN
$11.6B
| $9.03M | 0.03% |
125,143
-7,243
| -5% | -$476K |
|
505
Goodyear
GT
$2B
| $9.03M | 0.03% |
399,688
+6,458
| +2% | +$166K |
|
506
Jack Henry & Associates
JKHY
$10.9B
| $9.01M | 0.03% |
161,869
-22,063
| -12% | -$1.28M |
|
|
ANSS
507
DELISTED
Ansys
ANSS
| $8.95M | 0.03% |
118,236
+130
| +0.1% | +$10.2K |
|
508
SEI Investments
SEIC
$12.4B
| $8.88M | 0.03% |
245,678
-6,123
| -2% | -$218K |
|
|
MWV
509
DELISTED
MEADWESTVACO CORP
MWV
| $8.86M | 0.03% |
216,326
-6,069
| -3% | -$260K |
|
510
UDR
UDR
$12.3B
| $8.82M | 0.03% |
323,781
-10
| -0% | -$289 |
|
511
Fortune Brands Innovations
FBIN
$5.88B
| $8.81M | 0.03% |
250,873
-2,483
| -1% | -$86.8K |
|
512
Transocean
RIG
$5.89B
| $8.8M | 0.03% |
275,254
-1,294
| -0.5% | -$50.6K |
|
|
TWTC
513
DELISTED
TW TELECOM INC CL A COM
TWTC
| $8.8M | 0.03% |
211,475
-21,273
| -9% | -$866K |
|
514
United Therapeutics
UTHR
$25.8B
| $8.79M | 0.03% |
68,322
-2,124
| -3% | -$219K |
|
515
Herc Holdings
HRI
$5.02B
| $8.78M | 0.03% |
115,259
+32
| +0% | +$2.73K |
|
516
Everest Group
EG
$14.5B
| $8.76M | 0.03% |
54,095
+65
| +0.1% | +$10.5K |
|
|
TGNA
517
DELISTED
TEGNA Inc
TGNA
| $8.76M | 0.03% |
564,392
-12,737
| -2% | -$218K |
|
|
GAS
518
DELISTED
AGL Resources Inc
GAS
| $8.75M | 0.03% |
170,496
+2,426
| +1% | +$128K |
|
519
Alaska Air
ALK
$5.29B
| $8.74M | 0.03% |
200,781
+1,637
| +0.8% | +$75.9K |
|
520
Lennar Class A
LEN
$19.8B
| $8.74M | 0.03% |
236,394
-2,027
| -0.9% | -$75.2K |
|
|
SCG
521
DELISTED
Scana
SCG
| $8.71M | 0.03% |
175,604
-2,484
| -1% | -$127K |
|
522
RPM International
RPM
$13.7B
| $8.63M | 0.03% |
188,629
+3,887
| +2% | +$178K |
|
|
FLG
523
Flagstar Bank National Association
FLG
$5.93B
| $8.63M | 0.03% |
181,375
+1,767
| +1% | +$84.4K |
|
|
VMW
524
DELISTED
VMware, Inc
VMW
| $8.63M | 0.03% |
91,952
+412
| +0.5% | +$40.1K |
|
525
Darden Restaurants
DRI
$23.3B
| $8.62M | 0.03% |
187,485
-48,276
| -20% | -$2.04M |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.